Implementation of Therapy Together

NCT ID: NCT06040619

Last Updated: 2025-09-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-11-13

Study Completion Date

2026-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to learn about the implementation of Therapy Together, a pediatric constraint-induced movement therapy program in young children with unilateral cerebral palsy. The main question\[s\] it aims to answer are:

* Is the Therapy Together program effective in improving hand function and occupational performance compared to usual care?
* Is it feasible to implement the Therapy Together program within the standard care, early intervention framework?

Participants will participate in an 8-week pediatric constraint-induced movement therapy program. Researchers will compare the group completing the Therapy Together Program to a group that is receiving usual care to see if there is a difference in the change in hand function, occupational performance, and development.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A randomized waitlist control trial with early intervention therapists, infants/toddlers (ages 3 mo - 5 yrs 11 mo) with unilateral cerebral palsy (or at risk for developing cerebral palsy) and caregivers comparing Therapy Together to usual care followed by semi-structured interviews with caregivers and therapists will be utilized to examine the implementation and effectiveness of Therapy Together within early intervention.

Therapy Together Program:

The Therapy Together program includes caregiver education and coaching on implementing therapeutic activities that are play-based, age-appropriate, and tailored to meet goals to improve arm/hand function. The child and caregiver complete 8 sessions with their therapist. The therapist is trained to educate the caregiver on the Therapy Together program, demonstrate how to engage the child in therapeutic activities, and observe the caregiver implement the program during each weekly session. The first 7 intervention visits focus on constraint-induced movement therapy (CIMT) and the final intervention visit focuses on bimanual therapy (use of two hands).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cerebral Palsy Hemiplegic Cerebral Palsy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Pilot randomized control trial comparing treatment group to usual care. The usual care group will have the option to cross over to the treatment group after 8 weeks.
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Therapy Together

Participants will complete the 8-week Therapy Together program.

Group Type EXPERIMENTAL

Therapy Together

Intervention Type BEHAVIORAL

8-week caregiver-led pediatric constraint-induced movement therapy program

Usual Care

Participants will complete 8 weeks of usual care in early intervention.

Group Type ACTIVE_COMPARATOR

Usual Care

Intervention Type BEHAVIORAL

8 weeks of usual care received in an early intervention therapy program

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Therapy Together

8-week caregiver-led pediatric constraint-induced movement therapy program

Intervention Type BEHAVIORAL

Usual Care

8 weeks of usual care received in an early intervention therapy program

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* at risk for developing cerebral palsy or have been diagnosed with cerebral palsy
* children ages 3 months to 5 years 11 months
* present with asymmetric hand use
* present with a unilateral upper limb impairment
* able to visually attend to objects
* demonstrate an interest in objects
* attempt to reach for or grasp objects with the impaired upper extremity

Exclusion Criteria

* uncontrolled epilepsy
* significant visual impairment
* severe behavioral problems
* inability to complete the assessment protocol.
Minimum Eligible Age

3 Months

Maximum Eligible Age

71 Months

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

American Occupational Therapy Foundation

OTHER

Sponsor Role collaborator

Texas Scottish Rite Hospital for Children

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Angela Shierk

Clinical Scientist

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Angela Shierk, PhD

Role: PRINCIPAL_INVESTIGATOR

Scottish Rite for Children

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Scottish Rite for Children

Frisco, Texas, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Angela Shierk, PhD

Role: CONTACT

(469) 412-7172 ext. 1045

Heather Roberts, PhD

Role: CONTACT

(214) 794-8117

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Angela Shierk, PhD

Role: primary

469-412-7172

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

STU-2023-0553

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.